JAMIE JOSEPH: Open Payments
NPI 1912434002 · PRESTONSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$577 in 31 payments from 10 companies in 2025. Trend: 2023 $940 · 2024 $903 · 2025 $577
Food & beverage: $577
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $124 |
| PFIZER INC. | 6 | $109 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $76 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Novo Nordisk Inc | 3 | $67 |
| Abbott Laboratories | 2 | $36 |
| Boston Scientific Corporation | 1 | $33 |
| Lilly USA, LLC | 2 | $30 |
| Kestra Medical Technology Services, Inc. | 1 | $20 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $13 |
Products named: LEQVIO, Kerendia, ELIQUIS, Wegovy, FARXIGA, General - Therapies, BRILINTA, ZEPBOUND.
Industry payments across KY — which companies pay providers there.
